// App-Quantinova.ai

: Effectiveness of Standard-Dose Thromboprophylaxis with Enoxaparin in Preventing Recurrent Venous Thromboembolism in Pregnancy

Researchers

Presenter

  • Marie Claire McLintock

Principal Investigators

  • Renee Eslick

  • Stephanie Cox

Medical Centers

  • Auckland City Hospital, Auckland, New Zealand

  • Liverpool Hospital, Sydney, Australia

Locations

  • New Zealand

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved